CT26-hNECTIN4
Strain Information
검증 데이터
Fig1. NECTIN4 expression expression in CT26-hNECTIN4 cell lines.
Fig2. In vivo validation of CT26-hNECTIN4 in BALB/c mice.
BALB/c mice were inoculated with CT26-hNECTIN4 subcutaneously at 3×106 cells/mouse inoculum for tumor development.
Fig3. NECTIN4 expression in tumors after in vivo growth of CT26-hNECTIN4 in wild type BALB/c mice.
Fig4. NECTIN4 expression in tumors after in vivo growth of CT26-hNECTIN4 in wild type BALB/c mice.
Related Strain(s)
당신은 또한 좋아할 수 있습니다
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
조회At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
조회